Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

876
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
876
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
303

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum cytokine profiling reveals distinct inflammatory signatures in Kawasaki disease and MIS-C and suggests associations with coronary artery lesions.

Pediatric research·2026
Same author

Clinical Contexts of Detection of Benign Transient Hyperphosphatasemia in Infants and Young Children: A Single-Center Retrospective Study.

Cureus·2026
Same author

A Non-Fetal Chronic Residual Inflammatory Liver Phenotype After Transient Abnormal Myelopoiesis in Down Syndrome.

Pediatric blood & cancer·2026
Same author

Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study.

Journal of gastroenterology·2026
Same author

An Optimized PCR Assay to Detect <i>Escherichia Coli</i> Harboring the <i>astA</i> Gene Encoding the Enteroaggregative <i>E. coli</i> Heat-Stable Enterotoxin 1 in Various Food Matrices.

Food safety (Tokyo, Japan)·2025
Same author

Adult-Onset Neurological Deterioration in Dravet Syndrome Associated With a Novel SCN1A Missense Variant (p.Gly1371Asp): A Case Report.

Cureus·2025

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

630

Yersinia pseudotuberculosis-Associated Myositis.

Koji Yokoyama1, Mitsukazu Mamada1

  • 1Department of Pediatrics, Japanese Red Cross Wakayama Medical Center, Wakayama, JPN.

Cureus
|December 11, 2024
PubMed
Summary

A rare case of myositis developed in a child after Yersinia pseudotuberculosis infection. This post-infectious complication resolved with conservative care, highlighting awareness for clinicians.

Keywords:
antibioticsmyositispediatric reactive arthritistreatmentyersinia pseudotuberculosis infection

More Related Videos

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.3K
Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development
08:07

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development

Published on: July 1, 2020

7.6K

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

630
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.3K
Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development
08:07

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development

Published on: July 1, 2020

7.6K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Yersinia pseudotuberculosis (Y. pstb.) is a Gram-negative bacterium causing gastrointestinal infections like enterocolitis.
  • While reactive arthritis is a known complication, myositis is an exceptionally rare sequela.

Observation:

  • A five-year-old boy presented with fever, abdominal pain, and leg pain progressing to severe muscle weakness and inability to walk.
  • Laboratory tests revealed elevated inflammatory markers, and stool cultures confirmed Y. pseudotuberculosis infection.
  • MRI demonstrated muscle inflammation indicative of myositis.

Findings:

  • The patient experienced rapid improvement with conservative management, including rest and acetaminophen, without antibiotic intervention.
  • He remained asymptomatic 13 years post-infection, suggesting a favorable long-term prognosis.
  • This case documents the extremely rare occurrence of myositis following Y. pseudotuberculosis infection.

Implications:

  • The findings suggest a potential post-infectious, immune-mediated mechanism for myositis development after Y. pseudotuberculosis.
  • Clinicians should consider myositis in the differential diagnosis for children with muscle weakness following Y. pseudotuberculosis infection.
  • Conservative treatment approaches may be sufficient for managing this rare complication.